Resveratrol Prevents EBV Transformation and Inhibits the Outgrowth of EBV-Immortalized Human B Cells

被引:74
作者
Espinoza, J. Luis [2 ]
Takami, Akiyoshi [1 ]
Ly Quoc Trung [2 ]
Kato, Shunichi [3 ]
Nakao, Shinji [2 ]
机构
[1] Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan
[2] Kanazawa Univ, Kanazawa, Ishikawa, Japan
[3] Tokai Univ, Sch Med, Dept Cell Transplantat, Isehara, Kanagawa 25911, Japan
来源
PLOS ONE | 2012年 / 7卷 / 12期
关键词
EPSTEIN-BARR-VIRUS; NF-KAPPA-B; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS; LATENT MEMBRANE-PROTEIN-1; MIR-155; PROLIFERATION; EXPRESSION; APOPTOSIS; LYMPHOMA; STAT3;
D O I
10.1371/journal.pone.0051306
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Epstein Barr virus-associated lymphoproliferative disease is an increasing complication in patients with immunosuppressive conditions. Although the current therapies for this disorder are effective, they are also associated with significant toxicity. In an attempt to identify newer therapeutic agents, this study investigated the effects of Resveratrol, a naturally occurring polyphenolic compound, on the EBV transformation of human B cells. Methodology/Principal Findings: This study demonstrates that resveratrol prevents EBV transformation in human B cells. These effects are mediated by specific cytotoxic activities of resveratrol against EBV-infected B cells that are associated with the downregulation of the anti-apoptotic proteins Mcl-1 and survivin. This occurs as a consequence of the inhibition of EBV-induced NFkB and STAT-3 signaling pathways and a resveratrol-induced decrease in the expression of the oncogenic viral product LMP1 in EBV-infected B cells. In addition, resveratrol decreased the expression of miR-155 and miR-34a in EBV-infected B cells, blocked the expression of the anti-apoptotic viral gene BHRF1, and thus interrupted events that are critical for EBV transformation and the survival of EBV-transformed cells. Conclusions/Significance: These results suggest that resveratrol may therefore be a potentially effective therapeutic alternative for preventing EBV-associated lymphoproliferative diseases in immune compromised patients.
引用
收藏
页数:12
相关论文
共 44 条
[1]   Expression Profiling of Human Immune Cell Subsets Identifies miRNA-mRNA Regulatory Relationships Correlated with Cell Type Specific Expression [J].
Allantaz, Florence ;
Cheng, Donavan T. ;
Bergauer, Tobias ;
Ravindran, Palanikumar ;
Rossier, Michel F. ;
Ebeling, Martin ;
Badi, Laura ;
Reis, Bernhard ;
Bitter, Hans ;
D'Asaro, Matilde ;
Chiappe, Alberto ;
Sridhar, Sriram ;
Pacheco, Gonzalo Duran ;
Burczynski, Michael E. ;
Hochstrasser, Denis ;
Vonderscher, Jacky ;
Matthes, Thomas .
PLOS ONE, 2012, 7 (01)
[2]   Epstein-Barr virus provides a new paradigm: A requirement for the immediate inhibition of apoptosis [J].
Altmann, M ;
Hammerschmidt, W .
PLOS BIOLOGY, 2005, 3 (12) :2148-2157
[3]   Inhibition of STAT3 signaling induces apoptosis and decreases survivin expression in primary effusion lymphoma [J].
Aoki, Y ;
Feldman, GM ;
Tosato, G .
BLOOD, 2003, 101 (04) :1535-1542
[4]   Therapeutic potential of resveratrol:: the in vivo evidence [J].
Baur, Joseph A. ;
Sinclair, David A. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) :493-506
[5]   Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-κB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells [J].
Bhardwaj, Anjana ;
Sethi, Gautam ;
Vadhan-Raj, Saroj ;
Bueso-Ramos, Carlos ;
Takada, Yasunari ;
Gaur, Upasna ;
Nair, Asha S. ;
Shishodia, Shishir ;
Aggarwal, Bharat B. .
BLOOD, 2007, 109 (06) :2293-2302
[6]  
Blaes AH, 2010, EXPERT REV HEMATOL, V3, P35, DOI [10.1586/ehm.09.76, 10.1586/EHM.09.76]
[7]   Repeat Dose Study of the Cancer Chemopreventive Agent Resveratrol in Healthy Volunteers: Safety, Pharmacokinetics, and Effect on the Insulin-like Growth Factor Axis [J].
Brown, Victoria A. ;
Patel, Ketan R. ;
Viskaduraki, Maria ;
Crowell, James A. ;
Perloff, Marjorie ;
Booth, Tristan D. ;
Vasilinin, Grygoriy ;
Sen, Ananda ;
Schinas, Anna Maria ;
Piccirilli, Gianfranca ;
Brown, Karen ;
Steward, William P. ;
Gescher, Andreas J. ;
Brenner, Dean E. .
CANCER RESEARCH, 2010, 70 (22) :9003-9011
[8]   Antiviral activity of resveratrol [J].
Campagna, Michela ;
Rivas, Carmen .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2010, 38 :50-53
[9]   Resveratrol Inhibits Proliferation and Survival of Epstein Barr Virus-Infected Burkitt's Lymphoma Cells Depending on Viral Latency Program [J].
De Leo, Alessandra ;
Arena, Giuseppe ;
Stecca, Claudia ;
Raciti, Marisa ;
Mattia, Elena .
MOLECULAR CANCER RESEARCH, 2011, 9 (10) :1346-1355
[10]   NF-κB signaling modulation by EBV and KSHV [J].
de Oliveira, Deilson Elgui ;
Ballon, Gianna ;
Cesarman, Ethel .
TRENDS IN MICROBIOLOGY, 2010, 18 (06) :248-257